Several predictive factors for malignant IPMN have been reported, including dilated branch (30 mm), MPD dilatation, the presence of mural nodules, elevated CEA, and elevated CA19-9. This evidence concerns the gene CEACAM5 and pancreatic intraductal papillary-mucinous neoplasm.